Treatment of giant cell tumor of bone: Current concepts

Article English OPEN
Puri Ajay ; Agarwal Manish (2007)
  • Publisher: Wolters Kluwer Medknow Publications
  • Journal: Indian Journal of Orthopaedics, volume 41, issue 2, pages 101-108 (issn: 0019-5413, eissn: 1998-3727)
  • Related identifiers: pmc: PMC2989131, doi: 10.4103/0019-5413.32039
  • Subject: treatment | Curettage | Orthopedic surgery | RD701-811 | Symposium - Giant Cell Tumor | giant cell tumor

Giant cell tumor (GCT) of bone though one of the commonest bone tumors encountered by an orthopedic surgeon continues to intrigue treating surgeons. Usually benign, they are locally aggressive and may occasionally undergo malignant transformation. The surgeon needs to strike a balance during treatment between reducing the incidence of local recurrence while preserving maximal function. Differing opinions pertaining to the use of adjuvants for extension of curettage, the relative role of bone graft or cement to pack the defect and the management of recurrent lesions are some of the issues that offer topics for eternal debate. Current literature suggests that intralesional curettage strikes the best balance between controlling disease and preserving optimum function in the majority of the cases though there may be occasions where the extent of the disease mandates resection to ensure adequate disease clearance. An accompanying treatment algorithm helps outline the management strategy in GCT.
Share - Bookmark